EDMONTON, ALBERTA -- (MARKET WIRE) -- May 07, 2007 -- ViRexx Medical Corp. (“ViRexx”) (TSX: VIR) (AMEX: REX), is pleased to announce that at its Annual General Meeting of the Shareholders for the financial year ending December 31, 2006 held on May 3, 2007 as scheduled, Peter P. Smetek, Jr., Michael P. Marcus, Yves Cohen, Douglas Gilpin and Jacques LaPointe were elected to the Board of Directors. Peter P. Smetek remains Chairman of the Board and at a directors’ meeting held subsequent to the Annual General Meeting, Mr. Smetek was appointed Interim Chief Executive Officer.
